IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acura Pharmaceuticals Inc

CUSIP: 00509L953 | 3 institutional holders

Quarters

Q2 2015Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile